Company facts
- Industry
- Services-Medical Laboratories
- Headquarters
- Irving, Texas
- Most recent report
- 10-Q, filed Nov 4, 2026
- Incorporated
- Texas
- Filings on record
- 134 filings
- On EDGAR
- CIK 2019410
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Emerging growth company
Financials 6
News 8 of 12
Prospectuses and Registrations 5
Proxies 2
Ownership 8 of 87
- SCHEDULE 13G/A Large holder reported a passive stake, amended Nov 5, 2026
- 4 Insider reported a trade Sep 23, 2026
- 144 Notice of a proposed sale of restricted stock Sep 22, 2026
- 4 Insider reported a trade Sep 17, 2026
- 144 Notice of a proposed sale of restricted stock Sep 17, 2026
- 4 Insider reported a trade Sep 4, 2026
- 144 Notice of a proposed sale of restricted stock Sep 4, 2026
- 144 Notice of a proposed sale of restricted stock Sep 3, 2026
Other 8 of 22
- CERT Exchange certified a listing Jun 16, 2026
- 8-A12B Registration of a security for exchange listing Jun 16, 2026
- ARS Annual report sent to shareholders Apr 23, 2026
- EFFECT Notice that a registration became effective Jun 17, 2025
- CERT Exchange certified a listing Jun 17, 2025
- 8-A12B Registration of a security for exchange listing Jun 13, 2025
- CORRESP Reply to SEC staff Jun 13, 2025
- CORRESP Reply to SEC staff Jun 13, 2025
Everything here comes from Caris Life Sciences, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.